XML 35 R5.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements of Stockholders' Equity - USD ($)
Total
Series 1 Convertible Preferred Stock
Series 2 Convertible Preferred Stock
Common Stock
Additional Paid in Capital
Accumulated Deficit
Balance at Dec. 31, 2015 $ 6,167,959 $ 1,640,985 $ 521 $ 23,213,318 $ (18,686,865)
Balance, shares at Dec. 31, 2015   328,197 5,210,408    
Sale of Series 2 Preferred Stock 21,952,000 $ 21,952,000
Sale of Series 2 Preferred Stock, shares   21,952    
Fair value of warrants issued to placement agent in conjunction with sale of Series 2 Preferred Stock 150,451 150,451
Costs related to sale of Series 2 Preferred Stock (1,669,790) (1,669,790)
Provision for compensation expense related to issued stock options 136,308 136,308
Conversion of preferred stock to common stock $ (425,660) $ 5 425,655
Conversion of preferred stock to common stock, shares   (85,132) 51,873    
Exercise of stock options 42,500 $ 3 42,497
Exercise of stock options, shares   25,000    
Net loss (12,253,707) (12,253,707)
Balance at Dec. 31, 2016 14,525,721 $ 1,215,325 $ 21,952,000 $ 529 22,298,439 (30,940,572)
Balance, shares at Dec. 31, 2016   243,065 21,952 5,287,281    
Provision for compensation expense related to issued stock options 113,952 113,952
Conversion of preferred stock to common stock $ (18,300) 18,300
Conversion of preferred stock to common stock, shares   (3,660) 2,220    
Exercise of stock options 15,000 15,000
Exercise of stock options, shares       5,000    
Net loss (8,330,761)     (8,330,761)
Balance at Dec. 31, 2017 $ 6,323,912 $ 1,197,025 $ 21,952,000 $ 529 $ 22,445,691 $ (39,271,333)
Balance, shares at Dec. 31, 2017   239,405 21,952 5,294,501